Blog

WEBINAR VIDEO | Life Sciences Session #4: How to optimise your regulatory exclusivity rights for pharmaceutical products?

25/05/2021

LSS 4 tumb YT

In the fourth online Life Sciences Session our experts, Kirian Claeyé and Laura Traest, will be focusing on regulatory exclusivity rights for pharmaceutical products, which will include data exclusivity, orphan exclusivity, SPCs and paediatric rewards. They will navigate the maze of regulatory exclusivity rights, update you on a number of significant recent developments, and discuss what is still to come. Specific topics will include:

  • The SPC manufacturing waiver
  • The CJEU’s latest case-law on SPC rights: Santen and Royalty Pharma
  • The European Commission’s review of Orphan Exclusivity and Paediatric Extensions
  • The General Court’s very recent Polpharma ruling on Data Exclusivity

Contact

Kirian Claeyé

Managing Associate

Laura Traest

Associate

Want to stay tuned?

Subscribe here

follow us on